News Articles Tagged: Cancer Drug Enhancement

Betulinic Acid Derivatives: Enhancing Anticancer Efficacy and Solubility

Discover how Betulinic acid derivatives are improving anticancer efficacy and overcoming solubility issues. Learn about their synthesis and application, and find quality suppliers for your research needs.

Gimeracil (103766-25-2): A DPD Inhibitor for Cancer Treatment Research

Learn about Gimeracil (CAS 103766-25-2), its role as a DPD inhibitor in cancer therapy, and sourcing options from a leading Chinese manufacturer and supplier.

Oxfendazole in Oncology: Exploring New Frontiers in Cancer Treatment

Delve into the emerging research on Oxfendazole (CAS 53716-50-0) as a potential anti-cancer agent, focusing on its impact on NSCLC and synergistic effects with chemotherapy.

Synergistic Cancer Treatments: How 2'-Deoxycytidine Enhances Chemotherapy

Explore the synergistic potential of 2'-deoxycytidine with conventional chemotherapy agents, its role in sensitizing cancer cells, and its contribution to improved treatment outcomes.